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Objective: The aim of this study was to investigate the link between the hypertrophic phenotype of
chondrocytes and angiogenesis in osteoarthritis (OA) and more particularly to demonstrate that OA
hypertrophic chondrocytes potentially express a phenotype promoting angiogenesis through the
expression of factors controlling endothelial cells migration, invasion and adhesion.
Method: Human OA chondrocytes were cultivated in alginate beads in medium supplemented with 10%
fetal bovine serum (FBS) to induce chondrocyte hypertrophy. The hypertrophic phenotype was charac-
terized throughout 28 days of culture by measuring the expression of speciﬁc genes and by a microscopic
observation of cellular morphology. The effect of media conditioned by OA hypertrophic chondrocyte on
endothelial cells migration, invasion and adhesion was evaluated in functional assays. Moreover, hy-
pertrophic OA chondrocytes were tested for the expression of angiogenic factors by real-time RT-PCR.
Results: Speciﬁc markers of hypertrophy and observation of cellular morphology attested of the hyper-
trophic phenotype of chondrocytes in our culture model. Functional angiogenesis assays showed that
factors produced by hypertrophic chondrocytes stimulated migration, invasion and adhesion of endo-
thelial cells. Among the evaluated angiogenic factors, bone sialoprotein (BSP) was the most highly
upregulated in hypertrophic chondrocytes. The inhibition of endothelial cell adhesion by a GRGDS
peptide conﬁrmed the implication of RGD domain proteins, like BSP, in hypertrophic chondrocyte-
induced adhesion of endothelial cells.
Conclusion: Hypertrophic differentiation of chondrocyte may promote angiogenesis. Our ﬁndings
established the relation of BSP with OA chondrocyte hypertrophy and suggested that this factor could
constitute a potential target to control cartilage neovascularisation in OA.
 2013 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
Osteoarthritis (OA) is a joint disease implicating all joint tissues.
Particularly, the disease is characterized by a progressive degra-
dation of articular cartilage1,2. Modiﬁcations in OA cartilage meta-
bolism result in an imbalance between catabolic and anabolicY. Henrotin, Bone and Carti-
HU Sart-Tilman, 4000 Liege,
, christelle.sanchez@ulg.ac.be
cour), a.bellahcene@ulg.ac.be
(C. Baudouin), pmsika@
enrotin).
s Research Society International. Pactivities of cartilage3 but the exact mechanisms still need to be
speciﬁed. Hypertrophic differentiation of chondrocytes is a
commonly observed event in OA and is notably characterized by a
high expression of type X collagen4, runt-related factor 2 (runx2)5
and matrix metalloproteinase (MMP) 136. That change of pheno-
type leads to the production by chondrocytes of proteolytic
enzymes that mediate cartilage degradation7 and to the minerali-
zation and neovascularization of the extracellular matrix. To block
cartilage neovascularization has been considered as a promising
therapeutic target since it was shown that the development of
vascular structures in cartilage is closely related to innervation, a
phenomenon involved in nociception8.
The aim of our study was ﬁrstly to develop a culture model that
increased OA chondrocytes hypertrophy. Culture in alginate beadsublished by Elsevier Ltd. All rights reserved.
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the presence of 10% fetal bovine serum (FBS) in the culturemedium.
Chondrocyte phenotype was characterized by the analysis of spe-
ciﬁc hypertrophy markers and observation of cellular morphology.
This model was thereafter used to investigate the link between
enhanced hypertrophic phenotype of chondrocytes and functional
aspects of angiogenesis, i.e., migration, invasion and adhesion of
endothelial cells. By this way, we aimed to demonstrate that hy-
pertrophic OA chondrocytes promote angiogenesis in OA.
Material and methods
Chondrocyte culture in alginate beads
Human chondrocytes were isolated from cartilage of OA pa-
tients undergoing total knee replacement surgery with the
approval of the Ethic Committee of Medicine department of the
University of Liege (number B70720108313, reference 2010/43).
Alginate beads were prepared as previously described9 and osteo-
arthritic chondrocytes were embedded at a density of 4.2  106
cells per milliliter alginate solution. Cultures were realized with
chondrocytes coming from different pools of two to ﬁve OA pa-
tients that displayed a grade III or IV based on the classiﬁcation tree
for Collins grading of OA changes at the articular surface10. Each
culture condition was done in triplicate. Chondrocytes were culti-
vated for 28 days in Dulbecco’s modiﬁed Eagle’s medium (DMEM)
(Lonza, Verviers, Belgium) supplemented with 100U/ml penicillin-
100 mg/ml streptomycin solution (Lonza, Verviers, Belgium), 10 mM
4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES)
(Lonza, Verviers, Belgium), 20 mg/ml proline (SigmaeAldrich, Bor-
nem, Belgium), 50 mg/ml ascorbic acid (SigmaeAldrich, Bornem,
Belgium), 2 mM glutamine (Lonza, Verviers, Belgium) and either
10% fetal bovine serum (Lonza, Verviers, Belgium) or 2% ULTROSER
G (UG, Pall Corporation, France). ULTROSER G is composed of
diluted serum with additives such as hormones and steroids (i.e.,
dexamethasone), growth factors, minerals, and vitamins. Its exact
composition and concentration of each component are
conﬁdential.
Conditioned media preparation
After 3 and 21 days of culture in 10% FBS-supplemented
medium, human OA chondrocytes in alginate beads were
rinsed with DMEM and a 24 h FBS starvation period was applied.
Media conditioned during this 24 h were collected and 10 cul-
ture wells were pooled to be used as non-hypertrophic andTable 1
Sequence of forward and reverse primers used for PCR of the house-keeping gene (HPRT), m
bFGF, NGF, Ang1, TSP1, TSP2, MMP-2, OPN , ChM1).
Gene Forward prime
HPRT TGTAATGACCA
Collagen type X (col10a1) GGGAGTGCCA
Runt-related factor 2 (runx2) CTCCAACCCAC
Matrix Metalloproteinase-13 (MMP-13) CAACGGACCCA
Bone SialoProtein (BSP) GTGTCACTGGA
Vascular Endothelial Growth Factor (VEGF) TGCCTTGCTGC
basic Fibroblast Growth Factor (bFGF) AACATTGGAG
Nerve Growth Factor (NGF) CATCATCCCAT
Angiopoietin-1 (Ang1) ATTGAGTTAAT
Thrombospondin 1 (TSP1) CAGACCGCATT
Thrombospondin 2 (TSP2) AATGACGGTG
Matrix Metalloproteinase-2 (MMP-2) CCGTCGCCCAT
Osteopontin (OPN) CACGGACCTGC
Chondromodulin 1 (ChM1) GAACTCTGCGGhypertrophic conditioned medium in the functional angiogenesis
assays.
Histology
Alginate beads were processed for light microscopy by the
method described by Petit et al.11. The beads were ﬁxed for 4 h at
4C with 4% paraformaldehyde in 0.1 M sodium-cacodylate buffer
(pH 7.4) towhich 10mMCaCl2 was added to prevent disintegration.
After washing overnight at 4C in 0.1 M sodium-cacodylate buffer
containing 50 mM BaCl2, the beads were dehydrated in a series of
graded methanol washes followed by a xylene wash and ﬁnally
embedded in parafﬁn. Five micrometer sections were stained with
hematoxylin and eosin.
Enzymatic assays of alkaline phosphatase (AP) and nucleoside
triphosphate pyrophosphohydrolase (NTPPPH)
The enzymatic activity of AP was analyzed according to the
method described previously9. NTPPPH activity was quantiﬁed in
the cellular fraction. Fifty microliters of cell extract were incu-
bated with 200 ml of a 20 mM Tris, 0.15 M NaCl, 1 mM
50monophosphate p-nitrophenyl thymidine and 1.6 mM MgCl2
solution, pH 8.3. In the presence of NTPPPHs, 50monophosphate p-
nitrophenyl thymidine is transformed to p-nitrophenol and
thymidine 50-monophosphate (TMP). p-nitrophenol absorbance is
measured at 405 nm. A standard preparation of p-nitrophenol was
used for calibration. Enzymatic assay results were normalized to
the DNA content measured according to the ﬂuorimetric method
of Labarca and Paigen12. Enzymatic activity was expressed in
nanomoles of p-nitrophenol released per min and per microgram
of DNA.
Real-time RT-PCR of hypertrophy markers and angiogenic factors
RNA isolation, reverse transcription (RT) and polymerase chain
reaction (PCR) were performed as previously described13. The gene
hypoxanthine phosphoribosyltransferase (HPRT) was ampliﬁed
and used as an internal control to standardize messenger RNA
levels. Forward and reverse primer sequences used to amplify the
desired cDNA are presented in Table I.
Western blot analysis of bone sialoprotein (BSP)
Protein expression of BSP was analyzed by western blotting
with a mouse monoclonal anti-BSP antibody (1:300) (LFMb-24,arkers of hypertrophy (Col10a1, Runx2,MMP-13) and angiogenic factors (BSP, VEGF,
r Reverse primer
GTCAACAGGG TGCCTGACCAAGGAAAGC
TCATCG AGGGTGGGGTAGAGTT
GAATG CATCAGCGTCAACACC
TACAG ACAGACCATGTGTCCC
GCCAA ACCATCATAGCCATCGT
TCTAC CACACAGGATGGCTTGAA
GGAAACATC CGGGAGACAAGAAAACAC
CCCATCT GTACTGTTTGAATACACTGTTGTTAAT
GGACTGGGAAG AAATCAGCACCGTGTAAGA
GGAGATAC CCATCGTTGTCATCATCGTG
TGACCGA ACCCTCTCCATTGTTGTCT
CATCAA CAGTCCAAAGAACTTCTGCAT
CAGCAA GTGATGTCCTCGTCTGTAGC
TGACCTT TATTCAGTCTTCCAGCGCC
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concentrations were measured using the Micro BCA Protein assay
Kit (Thermo Scientiﬁc, Rockford, USA) according to the manu-
facturer’s instructions. Equal amounts of protein were separated
in a 7.5% SDS-polyacrylamide gel and were transferred to PVDF
membrane. After incubation with goat anti-mouse HRP second-
ary antibody (1:3000) (Dako, Heverlee, Belgium), proteins were
detected using enhanced chemoluminescence reagent (ECLþ)
(GE Healthcare, Diegem, Belgium). Chondrocyte production of
BSP was normalized to tubulin-a production detected with
mouse monoclonal antibody (1:1000) (sc-8035; Santa Cruz
Biotechnology Inc; Germany). Secretion of BSP by OA chon-
drocytes in culture media was normalized with a Ponceau red
staining of total proteins on PVDF membrane. Positive controls
consisted in cellular protein extracts and conditioned medium
from human osteosarcoma Saos-2 cells cultivated as previously
described14.Endothelial cells culture settings
Human Umbilical Vein Endothelial Cells (HUVECs) were ob-
tained from umbilical cords and were isolated and maintained in
culture as previously described15. Endothelial cells were cultivated
to 80% conﬂuence and a 1 h FBS starvation period was applied prior
to each functional assay.Monolayer wound healing assay
Two hundred and ﬁfty thousand endothelial cells were seeded
onto the two parallel wells of a silicon culture insert placed in a m-
dish (Proxylab, Beloeil, Belgium) and were grown to conﬂuence. A
500 mmgapwas introduced by removing the silicon insert resulting
in two separate patches of HUVECs that were overlaid with
conditioned culture media from OA non-hypertrophic or hyper-
trophic chondrocytes or control medium (non-conditioned culture
medium supplemented with 10% FBS). Wound closure, which
represents a measure of cell migration, was observed under a mi-
croscope at baseline and after 24 h incubation at 37C. Each con-
dition was made in triplicate and the experiment was performed
with conditioned media from three different cultures. Captured
images were analyzed with Image J Software (www.rsbweb.nih.
gov/ij/).Real-time functional angiogenesis assays settings
The effect of chondrocyte conditioned media was evaluated on
HUVECs migration and invasion with the xCELLigence real-time
cell analyzer (RTCA) dual-plate (DP) instrument (Roche Di-
agnostics, Vilvoorde, Belgium) that allowed a continuous and non-
invasive monitoring of cell response throughout the experiment.
Migration and invasion were assessed using speciﬁcally designed
plates (Roche Diagnostics, Vilvoorde, Belgium) in which cells can
move from the upper to the bottom well through a membrane
with 8 mm pores covered of electrodes. The modiﬁcation of elec-
tronic impedance was measured as cells attached to the elec-
trodes. Data were analyzed after 5, 10, 15, 20 and 25 h incubation
using RTCA Software. Measures of cell migration and invasion
were based on values of the Cell Index (CI). The CI is a dimen-
sionless parameter derived as a relative change in measured
electrical impedance to represent cell status. Non-conditioned
culture medium supplemented with 10% FBS was used as con-
trol. Experiments were repeated with conditioned media from
three independent cultures.Endothelial cells real-time migration assay
HUVECs were seeded in the upper wells of the plate at a density
of 40,000 cells per well in serum-free medium. Conditioned media
from OA chondrocytes or control medium were added in the bot-
tom wells. Each measure was done in quadruple.
Endothelial cells real-time invasion assay
Upper wells of the plate were coated either with 1/10 Becton
Dickinson (BD) Matrigel (VWR International, Louvain, Belgium) or
non-coated prior to the seeding of 20,000 HUVECs per well in
serum-free medium. OA chondrocyte conditioned media or control
medium were added in the bottom wells. Invasion of HUVECs
though the Matrigel coating was evaluated using the cell invasion
index (CII). The CII represents the ratio between the CI of Matrigel
coated and non-coated wells for the same experimental condition.
Each measure was done in sextuple.
Adhesion assay
Bacteriologic 96-well plates (Greiner Bio-one, Wemmel,
Belgium) were coated with OA chondrocyte conditioned media.
Coating of 10 mg/ml of recombinant BSP (R&D System, Abingdon,
United Kingdom) was used as a positive control and 10 mg/ml of
bovine serum albumin (BSA) (Thermo Scientiﬁc, Rockford, USA) as a
negative control. HUVECs were seeded at 3  104 cells per well.
After 2 h incubation at 37C, cells were gently washed with Dul-
becco’s phosphate buffer saline (DPBS) so only the nuclei of
attached cells were stained with crystal violet. The incorporated
dye was measured by reading the absorbance at 560 nm. The assay
was realized with media coming from three independent chon-
drocyte cultures. Each condition was done in sextuple.
Blocking of the integrin receptors of endothelial cells with GRGDS
HUVECs were pre-incubated with 50 nmol/l of GRGDS peptide
(Calbiochem,Merck Chemicals Ltd., United Kingdom) 1 h before use
in the assay in order to block HUVECs avb3 integrin receptors. As a
result, endothelial cells were not able to adhere to the substrate
anymore.
Statistical analysis
Statistical results were obtained using GraphPad Prism software,
version 6. Datawere analyzed by one-way ANOVA and if signiﬁcant,
followed by the suitable post-test (Dunnett’s or Tukey’s post-test)
and multiple comparisons test to obtain adjusted P-values. Com-
parison between two groups was performed with an F test to
compare variances. The Spearman nonparametric correlation test
was used to determine the existence of an association between
variables.
Results
Hypertrophic OA chondrocyte culture model
Different culture settings were compared in order to identify
which one induced an enhanced hypertrophic differentiation of OA
chondrocytes [Fig. 1(AeE)]. Cells were cultivated in alginate beads
for 28 days in culture medium supplemented with either 2% UG or
10% FBS and all parameters were analyzed every 3 or 4 days. A
lactate dehydrogenase activity (LDH) assay was performed to
ascertain that chondrocyte were not ongoing apoptosis. Whatever
the culture time or condition, cell death ratio remained below 5%
(data not shown). Hypertrophy was characterized by the expres-
sion of genes coding for speciﬁc markers of hypertrophy: type
OA chondrocytes cultivated in 
10% FBS supplemented medium
OA chondrocytes cultivated in 
2% UG supplemented medium
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Fig. 1. Evolution of the expression of hypertrophy markers (A) col10a1 (ANOVA: P < 0.0001), (B) runx2 (ANOVA: P ¼ 0.0002), (C) MMP13 (ANOVA: P < 0.0001), and the activity of
mineralization enzymes (D) AP (ANOVA: P < 0.0001) and (E) NTPPPH (ANOVA: P ¼ 0.0003) in OA chondrocytes cultivated in alginate beads for 28 days in medium supplemented
with either 2% ULTROSER G or 10% FBS. The increase of expression/activity of hypertrophy markers was signiﬁcant after 21 days (col10a1: P ¼ 0.0363; runx2: P ¼ 0.0379; MMP13:
P ¼ 0.0152; AP: P ¼ 0.0047; NTPPPH: P ¼ 0.0158), 24 days (col10a1: P ¼ 0.0012; runx2: P ¼ 0.0007; MMP13: P < 0.0001; AP: P ¼ 0.0126; NTPPPH: P ¼ 0.0103) and 28 days (col10a1:
P ¼ 0.0002; runx2: P ¼ 0.0208; MMP13: P < 0.0001; AP: P ¼ 0.0008; NTPPPH: P ¼ 0.0054) when compared with expression/activity after 3 days of culture. Comparison of hy-
pertrophy markers expression/activity by chondrocytes cultivated in FBS-enriched medium with the corresponding day of culture in 2% UG-supplemented medium revealed a
signiﬁcant increase after 21 days (runx2: P ¼ 0.0473; MMP13: P ¼ 0,0062; AP: P ¼ 0.0052; NTPPPH: P ¼ 0.0232) 24 days (col10a1: P ¼ 0.0031; runx2: P ¼ 0.0011; MMP13:
P < 0.0001; AP: P ¼ 0.0152; NTPPPH: P ¼ 0.0320) and 28 days of culture (col10a1: P ¼ 0.0015; runx2: P ¼ 0.0237; MMP13: P < 0.0001; AP: P ¼ 0.0011; NTPPPH: P ¼ 0.0183). Data
from three different chondrocytes cultures were collected every 3e4 days, normalized to the house-keeping gene HPRT or to the DNA content and presented in percentage of their
respective control. Data were analyzed by Dunnett’s test after one-way ANOVA and are presented with the mean  95% conﬁdence interval.
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speciﬁc enzymes, AP and NTPPPH. The time dependent increase of
these markers reﬂected that OA chondrocytes differentiated pro-
gressively to a highly hypertrophic state when cultivated in 10%
FBS-supplemented medium. This observation is demonstrated by a
signiﬁcant difference in culture conditions for col10a1 (P< 0.0001),
runx2 (P ¼ 0.0002) and MMP13 (P < 0.0001) expression and AP
(P< 0.0001) and NTPPPH (P¼ 0.0003) activity. Results also showed
a signiﬁcant increase of markers in 10% FBS but not 2% UG-
supplemented medium starting after 21 days of culture [Fig. 1(Ae
E)]. Moreover, statistical comparison between culture media
showed a signiﬁcant difference in the expression of each speciﬁc
marker of hypertrophy. These results attested the importance of
FBS in culture medium to increase chondrocyte hypertrophy.
Observation of sections of alginate beads demonstrated the pres-
ence, after 21 days of culture in 10% FBS-supplemented medium, of
numerous cells with increased intracellular volume, a morpho-
logical characteristic of hypertrophic cells (Fig. 2).
Based on these results, we considered that OA chondrocytes
cultivated in medium supplemented with 10% FBS for at least 21
days expressed a hypertrophic phenotype in opposition with OA
chondrocytes cultivated in alginate beads for 3 days in FBS-
enriched medium that were considered non-hypertrophic. The
culture media conditioned by human OA non-hypertrophic or hy-
pertrophic chondrocytes were used to assess the inﬂuence of
chondrocyte hypertrophy in the functional angiogenesis assays.
Indeed, factors contained in conditioned media might be able to
inﬂuence the different steps of the angiogenesis process.Inﬂuence of hypertrophy on wound healing
Wound healing was simulated by creating a gap in monolayer
HUVECs culture and by measuring gap ﬁlling in the presence of
non-hypertrophic or hypertrophic chondrocyte conditioned cul-
ture media. Wound healing was estimated after 24 h migration
(h24) and compared to baseline (h0). After 24 h, cells ﬁlled differ-
entially the gap depending on the conditioned media (ANOVA:
P ¼ 0.0005) or ﬁlled totally the gap in the positive control
[Fig. 3(A)]. The quantiﬁcation of this phenomenon revealed a sig-
niﬁcant reduction of 20% of the wound size with hypertrophic OA
chondrocyte culture medium (P < 0.001) and a signiﬁcant differ-
ence between non-hypertrophic and hypertrophic OA chondrocyte
conditioned media (P < 0.05) [Fig. 3(B)].
Inﬂuence of hypertrophy on real-time endothelial cell migration and
invasion
Endothelial cells migration and invasion under the inﬂuence of
non-hypertrophic and hypertrophic chondrocyte conditioned cul-
ture media were followed in real-time. Signiﬁcant differences were
observed throughout the study of endothelial cells migration
(ANOVA: P < 0.0001) [Fig. 3(C)]. Non-hypertrophic chondrocyte
conditioned culture media produced no signiﬁcant effect on HUVECs
migration whereas hypertrophic chondrocyte conditioned culture
media increased signiﬁcantly cell migration after 25 h (P < 0.001).
Endothelial cell invasion was stimulated in presence of chondrocyte
conditioned media (ANOVA: P < 0.0001) Non-hypertrophic
Fig. 2. Representative pictures of hematoxylin-eosin stained wax-embedded sections of OA chondrocytes cultivated in alginate beads during 3 days (A and B) or 21 days (C and D) in
medium supplemented with either 2% UG (A and C) or 10% FBS (B and D) (magniﬁcation 20).
L. Pesesse et al. / Osteoarthritis and Cartilage 21 (2013) 1913e1923 1917conditioned media showed an effect on cell invasion only observed
after 15 h (P < 0.01) whereas hypertrophic chondrocyte culture
medium provoked an early signiﬁcant increase in CII after 5 h of
stimulation (P < 0.01), reached a maximum after 10 h (P < 0.001)
and remained signiﬁcant until 15 h (P < 0.001). This stimulation
progressively decreased for the rest of the experiment.
Inﬂuence of hypertrophy on endothelial cell adhesion
A cell adhesion assay was performed to assess whether the
hypertrophic OA conditioned medium could mediate the adhesion
of HUVECs and thus favor the angiogenic process. Interestingly,
statistical analysis (ANOVA: P ¼ 0.0003) revealed that adhesion in
presence of hypertrophic chondrocyte conditioned medium was
similar than when recombinant BSP was used as a substrate and
was higher than adhesion with non-hypertrophic chondrocyte
conditioned medium (P < 0.05).
Screening of factors involved in angiogenesis
In order to link the hypertrophic phenotype of chondrocytes to a
possible angiogenic phenomenon, the expression of factors known
for their pro- or anti-angiogenic properties was analyzed by RT-
PCR. Table II presents the level of expression of each factor in
non-hypertrophic and hypertrophic conditions. The ratio between
expression after 21 days and 3 days was calculated to obtain the
variation of expression associated to hypertrophic differentiation of
chondrocytes. BSP was the most increased one with a ratio of
189.21. The expression of BSP was conﬁrmed to be signiﬁcantly
increased (P < 0.05) in the hypertrophic culture conditions
[Fig. 4(A)] and the western blot analysis of cellular protein extracts
and conditioned medium revealed that only hypertrophic chon-
drocytes produced and secreted the BSP protein [Fig. 4(B and C)]. A
65 kDa protein was found in cellular extracts and an approximately
85 kDa protein was detected in conditioned media. The reason of
these different sizes is most likely the higher content of post-translational modiﬁcations in the secreted form when compared
to the intracellular one. Indeed, it has been reported that these
modiﬁcations contribute to 40e50% to the mass of the protein16.
This is of note that culture in 2% UG-supplemented medium had no
effect on BSP expression and production by OA chondrocytes (data
not shown).
Correlation of BSP with markers of hypertrophy and mineralization
The association between BSP expression and those of speciﬁc
markers of hypertrophy and activity of mineralization enzymes
associated with hypertrophy was analyzed in non-hypertrophic
and hypertrophic conditions. Results showed a positive correla-
tion between the expression of BSP and col10a1 (r ¼ 0.51;
P < 0.0001), runx2 (r ¼ 0.58; P < 0.0001), MMP13 (r ¼ 0.39;
P¼ 0.0031) and the activity of AP (r ¼ 0.56; P ¼ 0.007) and NTPPPH
(r ¼ 0.77; P < 0.0001) (Fig. 5).
Implication of an RGD protein in HUVECs adhesion mediated by
hypertrophic chondrocytes conditioned media
The pre-treatment of HUVECs with a GRGDS peptide decreased
by 52% cells adhesion in the presence of hypertrophic conditioned
media (P < 0.01). In contrast, non-hypertrophic chondrocyte
conditioned media had no effect on endothelial cells adhesion
(ANOVA: P ¼ 0.0003) (Fig. 6).
Discussion
In this study, we characterized the phenotype of human OA
chondrocytes cultivated in alginate beads for 28 days in medium
supplemented with 10% FBS. In these conditions, chondrocytes
showed an increase of speciﬁc hypertrophy markers and typical
hypertrophic morphology. Based on this culture model, we inves-
tigated the effect of enhanced hypertrophy of OA chondrocytes on
functional aspects of the angiogenesis process.
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Fig. 3. Effect of non-hypertrophic (NH) and hypertrophic (H) OA chondrocyte conditioned media on wound healing by endothelial cells (HUVECS) (A and B), HUVECS real-time
migration (C), real-time invasion (D) and adhesion (E). (A) Representative pictures (magniﬁcation 10) of the wound healing experiment showing the gap in HUVECs at the
beginning of the experiment (h0) and after 24 h of incubation (h24); (B) Wound healing (ANOVA: P ¼ 0.0005) was quantiﬁed using image J SoftWare (www.rsbweb.nih.gov/ij/) and
data are presented in percentage of non-hypertrophic chondrocyte conditioned media at h0. Hypertrophic chondrocyte conditioned medium signiﬁcantly increased wound healing
by endothelial cells at h24 compared to h0 (P ¼ 0.0008) and compared to the effect of non-hypertrophic chondrocyte conditioned medium at h24 (P ¼ 0.0250). (C and D) Real-time
HUVECS migration (ANOVA: P < 0.0001) and invasion (ANOVA: P < 0.0001) were analyzed every 5 h on a period of 25 h. Hypertrophic chondrocyte conditioned medium
signiﬁcantly stimulated HUVECS migration after 25 h (P < 0.0001) and invasion was increased after 5 h (P ¼ 0.0087), 10 h (P < 0.0001) and 15 h (P < 0.0001) compared to control
condition and after 10 h (P < 0.0001) compared to non-hypertrophic chondrocyte conditioned medium (###). Non-hypertrophic chondrocyte conditioned medium stimulated
HUVECS invasion after 15 h (P ¼ 0.0041). In wound healing and real-time assays, control condition is a non-conditioned culture medium containing 10% FBS. (E) HUVECS adhesion
was analyzed after 2 h incubation of HUVECS on different coating conditions (ANOVA: P ¼ 0.0003). Hypertrophic chondrocyte conditioned medium signiﬁcantly increased HUVECS
adhesion (P ¼ 0.0463) compared to non-hypertrophic chondrocyte conditioned medium. Positive and negative controls are respectively coatings of 10 mg/ml recombinant BSP or
BSA. Data were analyzed by Tukey’s test after one-way ANOVA and are presented with mean  95% conﬁdence interval. Each data point is the mean of at least three measures and
each experiment was performed on three different chondrocytes cultures.
Table II
RT-PCR analysis of ten pro- and anti-angiogenic factors expression by human non-hypertrophic OA chondrocytes (cultivated 3 days in 10% serum-enriched medium) and
human hypertrophic OA chondrocytes (cultivated 21 days in 10% serum-enriched medium) normalized to HPRT expression. Values represent the mean of expression in three
different human OA chondrocytes cultures. The ratio between expression after 21 days and after 3 days represents the variation of expression associated to hypertrophic
differentiation of chondrocytes
Angiogenic factor Number of copies in non-hypertrophic
condition
Number of copies in hypertrophic
condition
Ratio hypertrophic/non-hypertrophic
BSP 950.93 105,694.64 111.15
Chondromodulin-1 1.09 12.97 11.85
Thrombospondin-2 15.79 119.82 7.59
Angiopoietin-1 0.90 5.67 6.32
MMP-2 36.34 198.88 5.47
Nerve growth factor 0.26 0.79 3.00
Basic ﬁbroblast growth factor 147.91 50.42 0.34
Thrombospondin-1 1473.20 469.77 0.32
Osteopontin 2348.16 508.94 0.22
Vascular endothelial growth factor 186.06 36.70 0.2
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Fig. 4. BSP detection in OA chondrocytes cultures by RT-PCR (A), western blot on
cellular protein extracts (B) and western blot on chondrocytes conditioned media (C).
(A) BSP gene expression by non-hypertrophic (NH) and hypertrophic (H) chondrocytes.
Data from three different chondrocytes cultures were analyzed by F test to compare
variances and are presented in percentage of control with the mean  95% conﬁdence
interval. The expression of BSP gene was signiﬁcantly higher in hypertrophic than in
non-hypertrophic chondrocytes (P ¼ 0.0001). (B) BSP production in cellular extracts
from NH and H chondrocytes. Equal protein loading was assessed by anti-tubulin-a
immunoblotting. (C) BSP secretion in conditioned chondrocyte media from NH and H
chondrocytes. Equal protein loading was assessed by Ponceau red staining. Molecular
weight difference in control and chondrocytes conditioned medium is discussed in the
discussion section. Western blot experiments were performed at least on three
different cultures and representative data from one experiment are shown. Control
(CTL) is constituted of Saos2 cellular protein extracts or conditioned medium.
L. Pesesse et al. / Osteoarthritis and Cartilage 21 (2013) 1913e1923 1919Primary OA chondrocytes were mixed with an alginate solution
to produce alginate beads, a three-dimensional environment that
mimics cartilage extracellular matrix. This culture model is classi-
cally used for chondrocyte cultures tomaintain cartilage phenotype
for a long-term period17. Indeed, the analysis of the expression of
two chondrocyte markers, aggrecan and type II collagen, in this
model showed that chondrocytes continued to express these
cartilage molecules for at least 28 days18. The analysis of speciﬁc
markers of chondrocyte hypertrophy revealed that cells cultivated
in 10% FBS-enriched medium undergo hypertrophic differentiation.
A signiﬁcant increase in the expression of speciﬁc hypertrophic
markers is initiated after 21 days of culture in 10% FBS-enrichedmedium in alginate matrix but not in media supplemented with
2% UG, a substitute of serum (exact composition unknown). These
observations asserted the speciﬁcity of the model.
We showed that hypertrophic differentiation of chondrocytes
was initiated by serum-enriched medium in long-term culture in
alginate beads. This matter suggests a role played by serum factors
and by the way a role that could be played by factors contained in
human blood serum during OA to inﬂuence the phenotype of
chondrocytes. In general, many molecules may be implicated in
hypertrophic differentiation such as growth factors, hormones,
extracellular matrixmolecules and proteases (see19 for review). The
hypertrophic state of chondrocytes is clearly identiﬁed in the
pathophysiology of OA (see20 for review). The differentiation of
chondrocytes is responsible for the elevated production of pro-
teolytic enzymes that mediates cartilage degradation such as
MMP13 and aggrecanases21,22. Therefore, inhibiting chondrocyte
hypertrophy could reduce cartilage damages. For this reason, the
change of phenotype constitutes an interesting target in the
treatment of OA and consequently represents an important phe-
nomenon to study and to understand.
To assess the hypertrophic phenotype of OA chondrocytes,
speciﬁc markers of hypertrophy were chosen according to the in-
formation available in the literature. Type X collagen and MMP13
are the most widely used markers of chondrocyte hypertrophy6.
The transcription factors runx2 has been shown to be associated
with chondrocyte hypertrophy several times23,24. AP and NTPPPH
take part in the process of cartilage matrix calciﬁcation associated
with chondrocyte hypertrophy25,26. In our model, chondrocytes
overproduced all these markers indicating that chondrocytes in
alginate beads cultivated with serum supplemented medium un-
dergo a progressive increased hypertrophic differentiation process
and constitute a relevant model for investigating the impact of this
process in OA cartilage. Hypertrophic chondrocytes, by the syn-
thesis of speciﬁc mediators, probably inﬂuence adjacent cells in
order to induce speciﬁc events. Angiogenesis could be one of them.
To verify this hypothesis, a functional analysis was carried out in
order to observe if hypertrophic chondrocyte conditioned media
contained factors that might be able to inﬂuence HUVECs behavior.
Migration, invasion and adhesion of endothelial cells take part in
the complex process of angiogenesis. Such functional studies have
previously been validated for migration27, invasion28 and adhe-
sion29 processes. The wound healing assay was demonstrative of
endothelial cells migration30. The experiments were performed
with HUVECswhich is themost commonly used human endothelial
cell type to study angiogenesis31,32.
Compared to non-hypertrophic, hypertrophic conditioned me-
dia stimulated HUVECs migration and invasion. The effect of non-
hypertrophic conditioned media on invasion after 15 h may be
explained by the fact that this conditioned media, although non-
hypertrophic in our model, comes from primary OA chondrocytes
culture. These chondrocytes initially present a pathological
phenotype and could already produce small amounts of factors that
could be able to activate the invasion process.
In the samemanner, hypertrophic OA chondrocytes conditioned
media showed a signiﬁcantly increased adhesion of HUVECs than
non-hypertrophic ones even if the latest have an effect on cell
adhesion which may also be explained by the pathological
phenotype of non-hypertrophic chondrocytes.
These observations allowed the conﬁrmation of the existence of
an association between hypertrophic differentiation of chon-
drocytes and different steps of the angiogenesis process. After 21
days of culture in serum-enriched medium, hypertrophic chon-
drocytes secrete factors that were able to promote endothelial cell
migration, invasion and adhesion and could therefore stimulate
angiogenesis.
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Fig. 5. Spearman’s correlation and corresponding P-value were calculated to assess the association between BSP expression and speciﬁc markers of chondrocyte hypertrophy (A)
collagen type X expression (P < 0.0001), (B) runx2 expression (P < 0.0001), (C) MMP13 expression (P ¼ 0.0031), (D) AP activity (P ¼ 0.007), (E) NTPPPH activity (P < 0.0001). Data
were collected from non-hypertrophic and hypertrophic OA chondrocytes (n ¼ 28).
L. Pesesse et al. / Osteoarthritis and Cartilage 21 (2013) 1913e19231920Angiogenesis is a closely integrated process in OA and may
contribute to its pathogenesis. Indeed, angiogenesis is implicated in
osteophytes development, subchondral bone remodeling and
cartilage mineralization. As cartilage is originally an avascular tis-
sue, invasion of articular cartilage by vascular structures is a
pathological process33,34. Neovascularization of cartilage enables
innervation of the tissue and may synergize with inﬂammation to
increase articular pain8,35.
In order to precise which factor could be implicated in cartilage
neovascularization, the expression of several factors chosenaccording to their known role in angiogenesis was analyzed. Both
activators and inhibitors were considered for the screening. VEGF36,
bFGF37, NGF38, OPN39, BSP40, and MMP241 are known to act as pro-
angiogenic factors whereas TSP 1 and 242 and ChM 143 were chosen
for their anti-angiogenic effect. Ang1 seems to have opposite effects
on angiogenesis depending on the situation and origin of endo-
thelial cells44e46. The activation of angiogenesis is basically the
result of an imbalance between pro- and anti-angiogenic factors.
The increased expression of angiogenesis activators leads to the
angiogenesis switch and acts positively on neovascularisation47,48.
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Fig. 6. Adhesion assay performed with a pre-incubation of HUVECS with the GRGDS
peptide at 50nmoles/l (ANOVA: P ¼ 0.0033). Blocking of HUVECS avb3 integrin re-
ceptors with the GRGDS reduced adhesion of HUVECs on hypertrophic chondrocyte
conditioned media coating (H þ GRGDS) with a signiﬁcant decrease of 52% in HUVECs
adhesion (P ¼ 0.0039). The GRGDS pre-treatment had no effect on non-hypertrophic
chondrocyte conditioned media coating (NH þ GRGDS). Data from three different
chondrocyte cultures were analyzed by Tukey’s test after one-way ANOVA. Each
experimental condition was performed in sextuple.
L. Pesesse et al. / Osteoarthritis and Cartilage 21 (2013) 1913e1923 1921Interestingly, the most expressed gene during hypertrophic differ-
entiation was that encoding BSP. We conﬁrmed this observation
with the RT-PCR analysis of BSP gene expression and the protein
analysis by western blot. The western blot analysis of hypertrophic
chondrocytes conditioned media revealed the presence of an
approximately 85 kDa form of BSP which is absent in Saos-2 cells
and non-hypertrophic chondrocytes conditioned medium. This
increased weight of BSP could be explained by post-translational
events such as glycosylation of the mature protein16. BSP has pre-
viously been described as a mediator of endothelial cells attach-
ment and migration through interaction between its ArgeGlyeAsp
(RGD) domain and HUVECs integrin receptors (avb3). In this work,
the authors concluded that BSP plays a role in angiogenesis. Re-
combinant BSP was also shown to stimulate ongoing angiogenesis
using the chicken chorio-allantoic membrane model40. Based on
these results, it is tempting to speculate that this RGD protein could
be implicated, at least in part, in the induction of the cartilage
neovascularisation process associated with chondrocyte hypertro-
phy in OA. Indeed, the effective blocking of the most representative
activated endothelial cell avb3 integrins with an RGD peptide prior
to the adhesion assay allowed to demonstrate the implication of an
RGD protein speciﬁcally present in hypertrophic chondrocyte
conditioned medium in HUVECs adhesion. Among the RGD extra-
cellular matrix proteins, BSP seems to be an interesting candidate
because of its known role in HUVECs attachment and migration.
We demonstrate that serum is necessary for hypertrophic
differentiation of OA chondrocytes in culture and we hypothesize
that hypertrophic chondrocytes produce factors that are respon-
sible for activation of migration, invasion and adhesion of endo-
thelial cells, three processes implicated in angiogenesis. We
believe that hypertrophy and neovascularization probably sustain
each other in a loop including an increased production of several
angiogenesis activators. Our study conﬁrms the association be-
tween chondrocyte hypertrophy and functional angiogenic
behavior of endothelial cells. It also strengthens the idea that
factors secreted by hypertrophic chondrocytes may play a role in
angiogenesis. In this study, we hypothesize that BSP could be one
of the RGD motif-containing factors produced by chondrocytes
that positively act on angiogenesis. To demonstrate this hypoth-
esis, the strategy would consist in the generation of a BSP-
depleted hypertrophic chondrocyte conditioned medium by theuse of speciﬁc neutralizing antibodies in order to observe the ef-
fects of BSP deprivation in endothelial cells functional angiogen-
esis assays. Appropriate antibodies for these experiments have
not been identiﬁed yet. Moreover, the precise role of BSP in OA, as
its relation with other OA mediators or its link with OA severity,
remains to be determined.
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